Skip Ribbon Commands
Skip to main content
    • Contact Us
    • One Hoag Drive,
      P.O. Box 6100
      Newport Beach, CA
      92658-6100
    • (949) 764-HOAG (4624)
    • feedback@hoag.org
    • Follow Us
    • Directory Listing

 
 

 AllNews

 
All News
  • Filter by Category 
  • 1 2 3 4 ...
  • Go To:
  • Robert Braithwaite named to Becker's Hospital Review's list of "100 Leaders of Great Hospitals in America"
    Excellence starts at the top, beginning with a crystal clear vision and a relentless pursuit toward an organization's mission. That's a tall order for hospitals facing one of the largest upheavals to the status quo in healthcare history. From 100 of the nation's great hospitals, these are the leaders who make them so.
    Read More
 
  • 5 Questions with Candi Rogers, on how she became Nurse of the Year
    ​Michigan native Candi Rogers said that to be successful in nursing, one should be a nurse at heart. Rogers was chosen as Hoag Hospital's Nurse of the Year this month after proving to her peers she is one of those nurses.
    Read More
 
  • Philanthropists Give $2.5 Million to Hoag Hospital
    ​Hoag Memorial Hospital Presbyterian received a historical $2.5 million donation this week from the the Argyros Family Foundation to expand nur​sing education, hospital officials announced Friday.
    Read More
 
  • Diabetes Couldn't Block CdM Grad from Olympic Gold
    ​Imagine being told at age 10 that you have Type 1 diabetes, that you have to monitor your blood sugar, inject yourself with insulin four times a day and become obsessive about everything that goes into your body.
    Read More
 
  • The New England Journal of Medicine Publishes Clinical Study of Minimally-Invasive Device for Treatment of Reflux Disease
    For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process.
    Read More